A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
Clinical trial NCT06578585 · COMPLETED
Trial details
- NCT number
- NCT06578585
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-13
- Primary completion
- 2025-07-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.